Q3 2025 Q linea AB Earnings Call Transcript

Oct 20, 2025 / 11:00 AM GMT

Release Date Price: kr1610

Transcript

Key Points

Positve

Q-linea AB (OSTO:QLINEA) experienced a strong quarter with increased demand for consumables and instruments.
The commercial pipeline is growing, with active discussions in over 15 countries, including new evaluations in Asia and Latin America.
The company has completed in-house production of discs, reducing the cost of goods and improving operational efficiency.
Q-linea AB (OSTO:QLINEA) has signed development partnerships with three pharmaceutical companies, enhancing their ability to bring new drugs to market.
The company is targeting a 10% reduction in operational costs through 2026, focusing on efficiency and resource allocation.

Negative

The quarter did not close as many contracts as hoped, with only 17 instruments in active routine use.
The overturning of a successful appeal in Italy has reduced visibility on nine instruments, impacting the upper end of their sales target.
The US government shutdown has delayed the submission of the version 2 menu to the FDA, potentially impacting timelines.
A significant portion of the customer pipeline is waiting for the version 2 menu clearance, which could delay sales.
The company is still working on securing additional financing and grants to support its operations and growth.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

QLINEA.ST - Q Linea AB
Q3 2025 Q linea AB Earnings Call
Oct 20, 2025 / 11:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello everyone. Welcome and thank you for joining this presentation of Qinia's Q3 report. You have Stuart Gander here, President CEO, and I'm joined by my CFO, Christer Samuelsson.

So we'll do this a little bit following our traditional process here, just a quick disclaimer that we'll take as read and understood.

And moving ahead to the topics for today. So I will start as usual with a commercial update. I will share, some of the feedback that we're getting from customers in our various interactions and some of that, word of mouth that's starting to spread, very nicely between customers. I will talk about our priorities here for Q4 to close out the year strong before handed over to Christer who walk through our financials for the

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.